Building Patient-Focused eCOA Strategies: Insights And Best Practices

Effective eCOA strategies help to measure how study participants are doing in near real-time in ways that ensure data accuracy and compliance with various regulatory guidance all over the world, the latter being a key reason that the U.S Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are supportive of the use of eCOA over paper outcome assessments. Most importantly, eCOA helps to make clinical research accessible for larger and broader ranges of patients, helping to increase inclusivity in patient populations while making research participation more realistic for dispersed populations and those whose conditions make clinical visits challenging.